• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辐射与生物还原药物 AQ4N 联合使用后的 DNA 损伤:对有氧和缺氧肿瘤细胞可能具有的选择性毒性。

DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells.

作者信息

Hejmadi M V, McKeown S R, Friery O P, McIntyre I A, Patterson L H, Hirst D G

机构信息

School of Biomedical Science, University of Ulster at Jordanstown, N. Ireland, UK.

出版信息

Br J Cancer. 1996 Feb;73(4):499-505. doi: 10.1038/bjc.1996.87.

DOI:10.1038/bjc.1996.87
PMID:8595165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2074454/
Abstract

AQ4N (1,4-bis-([2-(dimethylamino-N- oxide)ethyl]amino)5,8-dihydroxyanthracene-9,10-dione) is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound, AQ4. The alkaline comet assay was used to evaluate DNA damage induced by AQ4N and radiation. Cells prepared from freshly excised T50/80 murine tumours were shown to have the ability to reduce AQ4N to a DNA-damaging agent; this had disappeared within 24 h of excision. When T50/80 tumours implanted in BDF mice were exposed to radiation in vivo a considerable amount of DNA damage was present in tumours excised immediately. Minimal levels of DNA damage were detectable in tumours excised after 2-5 h. AQ4N given 30 min before radiation had no appreciable influence on this effect and AQ4N alone caused only a small amount of damage. When AQ4N and radiation were combined an increasing number of damaged cells were seen in tumours excised 24-96 h after irradiation. This was interpreted as evidence of the continued presence of AQ4, or AQ4-induced damage, which was formed in cells hypoxic at the time of administration of AQ4N. AQ4, a potent topoisomerase II inhibitor, would be capable of damaging cells recruited into the cell cycle following radiation damage to the well-oxygenated cells of the tumour. The kinetics of the expression of the DNA damage is consistent with this hypothesis and shows that AQ4 has persistent activity in vivo.

摘要

AQ4N(1,4-双([2-(二甲氨基-N-氧化物)乙基]氨基)-5,8-二羟基蒽醌-9,10-二酮)是一种新型的生物还原剂,可被还原为一种稳定的、与DNA有亲和力的化合物AQ4。碱性彗星试验用于评估AQ4N和辐射诱导的DNA损伤。结果显示,从新鲜切除的T50/80小鼠肿瘤制备的细胞具有将AQ4N还原为DNA损伤剂的能力;这种能力在切除后24小时内消失。当将植入BDF小鼠体内的T50/80肿瘤进行体内辐射时,立即切除的肿瘤中存在大量DNA损伤。在2-5小时后切除的肿瘤中可检测到最低水平的DNA损伤。在辐射前30分钟给予AQ4N对这种效应没有明显影响,单独使用AQ4N仅造成少量损伤。当AQ4N与辐射联合使用时,在照射后24-96小时切除的肿瘤中可见受损细胞数量增加。这被解释为在给予AQ4N时处于缺氧状态的细胞中持续存在AQ4或AQ4诱导损伤的证据。AQ4是一种有效的拓扑异构酶II抑制剂,能够损伤肿瘤中富氧细胞受到辐射损伤后进入细胞周期的细胞。DNA损伤表达的动力学与该假设一致,表明AQ4在体内具有持久活性。

相似文献

1
DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells.辐射与生物还原药物 AQ4N 联合使用后的 DNA 损伤:对有氧和缺氧肿瘤细胞可能具有的选择性毒性。
Br J Cancer. 1996 Feb;73(4):499-505. doi: 10.1038/bjc.1996.87.
2
AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo.AQ4N:一种具有生物还原潜力且在体内与辐射有正向相互作用的烷基氨基蒽醌氮氧化物。
Br J Cancer. 1995 Jul;72(1):76-81. doi: 10.1038/bjc.1995.280.
3
Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation mass spectrometry.通过成像基质辅助激光解吸/电离质谱法检测生物还原药物AQ4N及其活性代谢物AQ4在实体瘤中的分布。
Rapid Commun Mass Spectrom. 2007;21(7):1271-6. doi: 10.1002/rcm.2952.
4
Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent.生物还原激活的抗肿瘤药物AQ4N增强小鼠肿瘤的化疗和放疗效果
Br J Cancer. 2000 Jun;82(12):1984-90. doi: 10.1054/bjoc.2000.1163.
5
A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4N.一种细胞色素P450 2B6介导的基因治疗策略,用于增强与生物还原药物AQ4N联合使用时的放疗或环磷酰胺效果。
J Gene Med. 2005 Jul;7(7):851-9. doi: 10.1002/jgm.728.
6
Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.肿瘤选择性药物激活:一种利用细胞色素P450 1A1和AQ4N的基因导向酶前体药物疗法
Cancer Gene Ther. 2006 Jun;13(6):598-605. doi: 10.1038/sj.cgt.7700933.
7
Effects of AQ4N and its reduction product on radiation-mediated DNA strand breakage.AQ4N及其还原产物对辐射介导的DNA链断裂的影响。
Chem Biol Interact. 1999 Nov 15;123(1):1-10. doi: 10.1016/s0009-2797(99)00097-6.
8
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.使用细胞色素P450 3A4与AQ4N联合的生物还原基因导向酶解前药疗法。
Cancer Gene Ther. 2003 Jan;10(1):40-8. doi: 10.1038/sj.cgt.7700522.
9
Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N.叔胺氮氧化物作为生物还原药物:DACA氮氧化物、硝吖啶氮氧化物和AQ4N。
Br J Cancer Suppl. 1996 Jul;27:S43-7.
10
Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.将细胞毒性蒽醌类脂肪族氮氧化物用作前药DNA结合剂的原理:一类新型生物还原剂。
Cancer Metastasis Rev. 1993 Jun;12(2):119-34. doi: 10.1007/BF00689805.

引用本文的文献

1
The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.影像生物标志物在指导针对肿瘤缺氧的药物干预中的作用。
Front Pharmacol. 2022 Jul 15;13:853568. doi: 10.3389/fphar.2022.853568. eCollection 2022.
2
In vitro radiosensitization of breast cancer with hypoxia-activated prodrugs.缺氧激活前药增强乳腺癌的体外放射敏感性。
J Cell Mol Med. 2022 Aug;26(16):4577-4590. doi: 10.1111/jcmm.17486. Epub 2022 Jul 16.
3
Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs).针对缺氧肿瘤微环境中的 DNA 拓扑异构酶 IIα(TOP2A)使用单向缺氧激活前药(uHAPs)。
IUBMB Life. 2023 Jan;75(1):40-54. doi: 10.1002/iub.2619. Epub 2022 May 2.
4
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy.靶向缺氧:癌症治疗中的缺氧激活前药
Front Oncol. 2021 Jul 29;11:700407. doi: 10.3389/fonc.2021.700407. eCollection 2021.
5
Six degrees of separation: the oxygen effect in the development of radiosensitizers.六度分隔:增敏剂发展中的氧效应。
Transl Oncol. 2011 Aug;4(4):189-98. doi: 10.1593/tlo.11166. Epub 2011 Aug 1.
6
Single-cell gel electrophoresis (SCG)-A review and discussion.单细胞凝胶电泳(SCG)——综述与讨论。
Environ Health Prev Med. 1997 Jul;2(2):53-8. doi: 10.1007/BF02931964.
7
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.靶向细胞色素P450酶:抗癌药物研发的新方法。
Bioorg Med Chem. 2007 Aug 1;15(15):5047-60. doi: 10.1016/j.bmc.2007.05.046. Epub 2007 May 23.
8
The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N.新型生物还原药物 AQ4N 对顺铂的化学增敏作用。
Br J Cancer. 2001 Aug 17;85(4):625-9. doi: 10.1054/bjoc.2001.1975.
9
Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent.生物还原激活的抗肿瘤药物AQ4N增强小鼠肿瘤的化疗和放疗效果
Br J Cancer. 2000 Jun;82(12):1984-90. doi: 10.1054/bjoc.2000.1163.

本文引用的文献

1
The experimental development of bioreductive drugs and their role in cancer therapy.生物还原药物的实验进展及其在癌症治疗中的作用。
Cancer Metastasis Rev. 1993 Jun;12(2):73-82. doi: 10.1007/BF00689802.
2
Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.将细胞毒性蒽醌类脂肪族氮氧化物用作前药DNA结合剂的原理:一类新型生物还原剂。
Cancer Metastasis Rev. 1993 Jun;12(2):119-34. doi: 10.1007/BF00689805.
3
Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone.氧分压分布足以解释仅接受放疗的人类乳腺肿瘤的局部反应。
Int J Radiat Oncol Biol Phys. 1993 Jul 15;26(4):631-6. doi: 10.1016/0360-3016(93)90280-9.
4
Radiation-induced reoxygenation in the SCCVII murine tumour: evidence for a decrease in oxygen consumption and an increase in tumour perfusion.SCCVII 小鼠肿瘤中的辐射诱导再氧合:耗氧量降低和肿瘤灌注增加的证据。
Radiother Oncol. 1994 Jul;32(1):37-46. doi: 10.1016/0167-8140(94)90447-2.
5
EO9: relationship between DT-diaphorase levels and response in vitro and in vivo.EO9:DT-黄递酶水平与体内外反应之间的关系。
Br J Cancer. 1995 Jun;71(6):1199-203. doi: 10.1038/bjc.1995.233.
6
The single cell gel electrophoresis assay (comet assay): a European review.单细胞凝胶电泳试验(彗星试验):一项欧洲综述。
Mutat Res. 1993 Jul;288(1):47-63. doi: 10.1016/0027-5107(93)90207-v.
7
Aliphatic amine N-oxides of DNA binding agents as bioreductive drugs.作为生物还原药物的DNA结合剂的脂肪族胺N-氧化物
Oncol Res. 1994;6(10-11):533-8.
8
AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo.AQ4N:一种具有生物还原潜力且在体内与辐射有正向相互作用的烷基氨基蒽醌氮氧化物。
Br J Cancer. 1995 Jul;72(1):76-81. doi: 10.1038/bjc.1995.280.
9
Variability in the expression of xenobiotic-metabolizing enzymes during the growth cycle of rat hepatoma cells.大鼠肝癌细胞生长周期中异生物代谢酶表达的变异性。
Xenobiotica. 1985 Aug-Sep;15(8-9):781-7. doi: 10.3109/00498258509047441.
10
A simple technique for quantitation of low levels of DNA damage in individual cells.一种用于定量单个细胞中低水平DNA损伤的简单技术。
Exp Cell Res. 1988 Mar;175(1):184-91. doi: 10.1016/0014-4827(88)90265-0.